Literature DB >> 1086170

Clinical observations on treatment of alkylmercury poisoning in hospital patients.

F Bakir, A Al-Khalidi, T W Clarkson, R Greenwood.   

Abstract

Twenty-six patients suffering from methylmercury poisoning were treated by different therapeutic regimes. Seven received penicillamine or N-acetyl-d-L-penicillamine, 10 were treated with dimercaprol sulfonate and 9, who could not be treated, were given a placebo and were used as controls. Penicillamine, N-acetyl-d-L-penicillamine, and dimercaprol sulfonate reduced the blood level of mercury and increased its urinary excretion. No appreciable clinical improvement was noticed among the severe or very severe cases, while mild or moderate cases improved clinically irrespective of the treatment given.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086170      PMCID: PMC2366399     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  An extracorporeal complexing hemodialysis system for the treatment of methylmercury poisoning. I. In vitro studies of the effects of four complexing agents on the distribution and dialyzability of methylmercury in human blood.

Authors:  P J Kostyniak; T W Clarkson; R V Cestero; R B Freeman; A H Abbasi
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

  1 in total
  2 in total

1.  Clinical and epidemiological aspects of methylmercury poisoning.

Authors:  F Bakir; H Rustam; S Tikriti; S F Al-Damluji; H Shihristani
Journal:  Postgrad Med J       Date:  1980-01       Impact factor: 2.401

2.  Therapeutic Efficacy of the N,N' Bis-(2-Mercaptoethyl) Isophthalamide Chelator for Methylmercury Intoxication in Caenorhabditis elegans.

Authors:  Tao Ke; Julia Bornhorst; Tanja Schwerdtle; Abel Santamaría; Félix Alexandre Antunes Soare; João B T Rocha; Marcelo Farina; Aaron B Bowman; Michael Aschner
Journal:  Neurotox Res       Date:  2020-03-31       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.